Ampio Pharmaceuticals (AMPE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Operating Expenses | 11,184 | 15,676 | 17,082 | 24,168 | 31,448 |
| Operating Income | -11,184 | -15,676 | -17,082 | -24,168 | -31,448 |
| Other Income | 45,170 | -36,216 | -2,081 | 60 | 143 |
| Pre-tax Income | 33,986 | -51,892 | -19,164 | -24,108 | -31,305 |
| Net Income Continuous | 33,986 | -51,892 | -19,164 | -24,108 | -31,305 |
| Net Income Discontinuous | N/A | N/A | N/A | -9,606 | -7,744 |
| Minority Interests | N/A | N/A | N/A | -1,704 | -923 |
| Net Income | $33,986 | $-51,892 | $-19,164 | $-32,010 | $-38,125 |
| EPS Basic Total Ops | 137.93 | -236.88 | -107.95 | -185.91 | -227.89 |
| EPS Basic Continuous Ops | 138.92 | -238.29 | -107.95 | -137.93 | -185.91 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | -47.98 | -41.98 |
| EPS Diluted Total Ops | -35.98 | -236.88 | -107.95 | -185.91 | -227.89 |
| EPS Diluted Continuous Ops | 111.87 | -238.29 | -107.95 | -137.93 | -185.91 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | -47.98 | -41.98 |
| EPS Diluted Before Non-Recurring Items | 44.98 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-9,903 | $-14,138 | $-15,724 | $-23,199 | $-30,993 |